• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Concentra Announces the Appointment Of Vipin Gopal and Brigid Bonner To Its Board Of Directors

    6/26/25 4:30:00 PM ET
    $CON
    Medical Specialities
    Health Care
    Get the next $CON alert in real time by email

    Concentra® Group Holdings Parent, Inc. ("Concentra") (NYSE:CON), today announced the appointment of Vipin Gopal and Brigid Bonner to the Concentra Board of Directors, marking a strategic milestone for the occupational health services company.

    "We are pleased to welcome Vipin Gopal and Brigid Bonner to the Concentra Board," said Bob Ortenzio, Concentra's board chair. "As Concentra navigates growth and the opportunity to increase shareholder value, expanding the Board with two prominent health care leaders with data, technology, and business transformation expertise will prove to be a mobilizing force for the company."

    Vipin Gopal, PhD, brings over 25 years of experience successfully leading data, AI, and digital transformation of Fortune 100 companies. He is a recognized thought leader in leveraging technology to maximize business value, with broad health care industry experience gained through roles across payor, provider, pharmaceutical, and retail pharmacy organizations.

    Gopal has served as the Chief Data and Analytics Officer at two major companies: Eli Lilly and Company and Walgreens Boots Alliance. In these roles, he was the enterprise executive leader responsible for driving next-generation data and AI strategy and operations across various lines of business. Previously, he was the senior vice president of analytics at Humana and held leadership roles at Cigna, United Technologies Corporation, and Honeywell.

    Gopal obtained his doctorate from Carnegie Mellon University and B.Tech. from the Indian Institute of Technology (IIT), Bombay, both in engineering, and holds an MBA from the NYU Stern School of Business.

    "Concentra analyzes vast amounts of health care data, empowering our clinicians by providing them with valuable insights for superior clinical decision making," said Keith Newton, Concentra's chief executive officer. "And, with AI expected to revolutionize numerous aspects of care, Vipin will apply his deep knowledge to help provide guidance to the Concentra organization moving forward."

    Brigid Bonner is the president of Bonner Consulting, a firm focused on strategy and digital and personal transformation. She leverages her expertise to help leaders chart their course, whether in pursuit of personal life planning or organizational strategy. Her specialties include strategic planning, business development, digital transformation, consumer experience, and strategic coaching.

    Bonner has over 35 years of experience as a senior executive traversing nonprofit, for-profit, start-up, and Fortune 100 organizations. Her industry expertise includes retail, technology, e-commerce, and health care. She has held senior leadership roles with CaringBridge, UnitedHealth Group, IBM, Target Corporation, The Schwan Food Company, and SimonDelivers.com.

    Bonner earned her Bachelor of Science degree from Iowa State University, with a double major in journalism/advertising and industrial administration, and her Master of Business Administration degree from Harvard Business School.

    "Brigid has made significant contributions to the success of many innovative, high-growth businesses in the health care industry," continued Newton. "As the health care landscape continues to become more complex with broad trends in technology innovation at the forefront, Brigid joins the board at a most opportune time, and we welcome her contributions."

    Founded in 1979, Concentra has played a significant role in creating the workplace health industry model that exists today. Our national presence enables us to provide access to high-quality care that supports our mission to improve the health of America's workforce. With these two new appointments, the Concentra Board of Directors expands to seven members, composed of outstanding leaders in medicine, finance, and health care organizational management. To learn more, visit www.Concentra.com.

    About Concentra

    Concentra is the largest provider of occupational health services in the United States by number of locations, with the mission of improving the health of America's workforce, one patient at a time. Our approximately 12,000 colleagues and affiliated physicians and clinicians support the delivery of an extensive suite of services, including occupational and consumer health services and other direct-to-employer care. We support the care of approximately 50,000 patients each day on average across 45 states at our 627 occupational health centers, 160 onsite health clinics at employer worksites, and Concentra Telemed as of March 31, 2025.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250626577227/en/

    Lynn Craig

    610-739-8003

    [email protected]

    Get the next $CON alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $CON

    DatePrice TargetRatingAnalyst
    12/16/2024$24.00Neutral → Buy
    BofA Securities
    10/7/2024$30.50 → $24.00Buy → Neutral
    BofA Securities
    8/20/2024$33.00Outperform
    RBC Capital Mkts
    8/19/2024Buy
    BofA Securities
    8/19/2024$29.00Buy
    Deutsche Bank
    8/19/2024$29.00Overweight
    JP Morgan
    8/19/2024$32.00Buy
    Goldman
    8/19/2024$28.00Outperform
    Mizuho
    More analyst ratings

    $CON
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 3 filed by new insider Gopal Vipin

      3 - Concentra Group Holdings Parent, Inc. (0002014596) (Issuer)

      7/2/25 8:52:23 PM ET
      $CON
      Medical Specialities
      Health Care
    • SEC Form 3 filed by new insider Bonner Brigid A.

      3 - Concentra Group Holdings Parent, Inc. (0002014596) (Issuer)

      7/1/25 7:03:18 PM ET
      $CON
      Medical Specialities
      Health Care
    • Director Ortenzio Robert A disposed of 3,070,367 shares and acquired 1,023,455 shares (SEC Form 4)

      4 - Concentra Group Holdings Parent, Inc. (0002014596) (Issuer)

      3/4/25 4:59:26 PM ET
      $CON
      Medical Specialities
      Health Care

    $CON
    Financials

    Live finance-specific insights

    See more
    • Concentra® to Announce Second Quarter 2025 Results on Thursday, August 7, 2025

      Concentra® Group Holdings Parent, Inc. ("Concentra") (NYSE:CON) will release the financial results for its second quarter ended June 30, 2025, on Thursday, August 7, 2025, after the market closes. Concentra will host a conference call regarding its financial results on Friday, August 8, 2025, at 9 a.m. Eastern Time. The conference call will be a live webcast and can be accessed via this Earnings Call Webcast Link or via Concentra's website at https://ir.concentra.com. A replay of the webcast will be available shortly after the call at the same locations. Participants may join the audio-only version of the webcast or participate in the question-and-answer session by calling: Toll Free:

      7/7/25 4:30:00 PM ET
      $CON
      Medical Specialities
      Health Care
    • Concentra Group Holdings Parent, Inc. Announces Results For Its First Quarter Ended March 31, 2025, Cash Dividend, and Revised FY 2025 Guidance

      Concentra Group Holdings Parent, Inc. ("Concentra," the "Company," "we," "us," or "our") (NYSE:CON), the nation's largest provider of occupational health services, today announced results for its first quarter ended March 31, 2025, and the declaration of a cash dividend. "Concentra reported a solid start to 2025 with strong revenue and Adjusted EBITDA growth in the first quarter. With a deep understanding of patient and client needs and market dynamics, we continue to execute on key drivers of growth and deliver a comparative market advantage. Maintaining this focus ensures we continue to achieve our strategic business objectives for the year," said Keith Newton, Chief Executive Officer of

      5/7/25 4:30:00 PM ET
      $CON
      Medical Specialities
      Health Care
    • Concentra® Announces Signing of Definitive Agreement to Acquire Pivot Onsite Innovations

      Concentra Group Holdings Parent, Inc. ("Concentra," "the Company," "we," "us," or "our") (NYSE:CON), the nation's largest provider of occupational health services, today announced the signing of a definitive agreement to acquire Pivot Onsite Innovations from Athletico Physical Therapy. Pivot Onsite Innovations is a leader in the onsite health industry with over 200 onsite health clinics at employer locations in over 40 states. "Joining forces with Pivot Onsite Innovations represents an exciting new chapter for Concentra Onsite Health," said Matt DiCanio, Concentra's President and Chief Financial Officer. "Since 1993, our onsite health clinics have provided employees with immediate access t

      4/21/25 9:00:00 AM ET
      $CON
      Medical Specialities
      Health Care

    $CON
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Concentra® to Announce Second Quarter 2025 Results on Thursday, August 7, 2025

      Concentra® Group Holdings Parent, Inc. ("Concentra") (NYSE:CON) will release the financial results for its second quarter ended June 30, 2025, on Thursday, August 7, 2025, after the market closes. Concentra will host a conference call regarding its financial results on Friday, August 8, 2025, at 9 a.m. Eastern Time. The conference call will be a live webcast and can be accessed via this Earnings Call Webcast Link or via Concentra's website at https://ir.concentra.com. A replay of the webcast will be available shortly after the call at the same locations. Participants may join the audio-only version of the webcast or participate in the question-and-answer session by calling: Toll Free:

      7/7/25 4:30:00 PM ET
      $CON
      Medical Specialities
      Health Care
    • Concentra Announces the Appointment Of Vipin Gopal and Brigid Bonner To Its Board Of Directors

      Concentra® Group Holdings Parent, Inc. ("Concentra") (NYSE:CON), today announced the appointment of Vipin Gopal and Brigid Bonner to the Concentra Board of Directors, marking a strategic milestone for the occupational health services company. "We are pleased to welcome Vipin Gopal and Brigid Bonner to the Concentra Board," said Bob Ortenzio, Concentra's board chair. "As Concentra navigates growth and the opportunity to increase shareholder value, expanding the Board with two prominent health care leaders with data, technology, and business transformation expertise will prove to be a mobilizing force for the company." Vipin Gopal, PhD, brings over 25 years of experience successfully lead

      6/26/25 4:30:00 PM ET
      $CON
      Medical Specialities
      Health Care
    • Concentra® Announces Closing of Pivot Onsite Innovations Acquisition

      Concentra Group Holdings Parent, Inc. ("Concentra," "the Company," "we," "us," or "our") (NYSE:CON), the nation's largest provider of occupational health services, today announced the closing of the transaction to acquire Pivot Onsite Innovations from Athletico Physical Therapy. Pivot Onsite Innovations is a leader in the onsite health industry with over 200 onsite health clinics at employer locations in over 40 states. "We are very excited about the addition of Pivot Onsite Innovations to Concentra Onsite Health," said Matt DiCanio, Concentra's President and Chief Financial Officer. "This collaboration doubles the size of our growing Concentra Onsite Health operating segment and fully al

      6/2/25 9:00:00 AM ET
      $CON
      Medical Specialities
      Health Care

    $CON
    SEC Filings

    See more
    • Amendment: SEC Form SCHEDULE 13G/A filed by Concentra Group Holdings Parent Inc.

      SCHEDULE 13G/A - Concentra Group Holdings Parent, Inc. (0002014596) (Subject)

      7/7/25 1:20:33 PM ET
      $CON
      Medical Specialities
      Health Care
    • Concentra Group Holdings Parent Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Concentra Group Holdings Parent, Inc. (0002014596) (Filer)

      6/26/25 4:37:09 PM ET
      $CON
      Medical Specialities
      Health Care
    • Concentra Group Holdings Parent Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Concentra Group Holdings Parent, Inc. (0002014596) (Filer)

      6/2/25 9:41:15 AM ET
      $CON
      Medical Specialities
      Health Care

    $CON
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Concentra Group Holdings Parent upgraded by BofA Securities with a new price target

      BofA Securities upgraded Concentra Group Holdings Parent from Neutral to Buy and set a new price target of $24.00

      12/16/24 6:50:31 AM ET
      $CON
      Medical Specialities
      Health Care
    • Concentra Group Holdings Parent downgraded by BofA Securities with a new price target

      BofA Securities downgraded Concentra Group Holdings Parent from Buy to Neutral and set a new price target of $24.00 from $30.50 previously

      10/7/24 7:46:54 AM ET
      $CON
      Medical Specialities
      Health Care
    • RBC Capital Mkts initiated coverage on Concentra Group Holdings Parent with a new price target

      RBC Capital Mkts initiated coverage of Concentra Group Holdings Parent with a rating of Outperform and set a new price target of $33.00

      8/20/24 6:52:13 AM ET
      $CON
      Medical Specialities
      Health Care

    $CON
    Leadership Updates

    Live Leadership Updates

    See more
    • Concentra Announces the Appointment Of Vipin Gopal and Brigid Bonner To Its Board Of Directors

      Concentra® Group Holdings Parent, Inc. ("Concentra") (NYSE:CON), today announced the appointment of Vipin Gopal and Brigid Bonner to the Concentra Board of Directors, marking a strategic milestone for the occupational health services company. "We are pleased to welcome Vipin Gopal and Brigid Bonner to the Concentra Board," said Bob Ortenzio, Concentra's board chair. "As Concentra navigates growth and the opportunity to increase shareholder value, expanding the Board with two prominent health care leaders with data, technology, and business transformation expertise will prove to be a mobilizing force for the company." Vipin Gopal, PhD, brings over 25 years of experience successfully lead

      6/26/25 4:30:00 PM ET
      $CON
      Medical Specialities
      Health Care
    • Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600

      NEW YORK, Nov. 19, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600: Flex Ltd (NASD: FLEX) will replace Azenta Inc. (NASD: AZTA) in the S&P MidCap 400, and Azenta will replace Envestnet Inc. (NYSE:ENV) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, November 25. Bain Capital is acquiring Envestnet in a deal expected to be completed soon, pending final closing conditions. Azenta's market capitalization is no longer representative of the mid-cap market space.Concentra Group Holdings Inc. (NYSE:CON) will replace Myers Industries Inc. (NYSE:MYE) in the S&P SmallCap 600 effective prior to the openin

      11/19/24 5:56:00 PM ET
      $AZTA
      $CON
      $ENV
      $FLEX
      Industrial Machinery/Components
      Technology
      Medical Specialities
      Health Care

    $CON
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Concentra Group Holdings Parent Inc.

      SC 13G - Concentra Group Holdings Parent, Inc. (0002014596) (Subject)

      12/9/24 6:02:26 AM ET
      $CON
      Medical Specialities
      Health Care
    • SEC Form SC 13G filed by Concentra Group Holdings Parent Inc.

      SC 13G - Concentra Group Holdings Parent, Inc. (0002014596) (Subject)

      12/6/24 4:32:57 PM ET
      $CON
      Medical Specialities
      Health Care
    • SEC Form SC 13D filed by Concentra Group Holdings Parent Inc.

      SC 13D - Concentra Group Holdings Parent, Inc. (0002014596) (Subject)

      12/3/24 4:21:17 PM ET
      $CON
      Medical Specialities
      Health Care